Cowen Prime Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $485K | Hold |
6,000
| – | – | 0.17% | 59 |
|
|
2023
Q1 | $501K | Sell |
6,000
-500
| -8% | -$35.5K | 0.2% | 60 |
|
|
2022
Q4 | $440K | Hold |
6,500
| – | – | 0.18% | 59 |
|
|
2022
Q3 | $324K | Hold |
6,500
| – | – | 0.19% | 56 |
|
|
2022
Q2 | $362K | Hold |
6,500
| – | – | 0.21% | 57 |
|
|
2022
Q1 | $361K | Hold |
6,500
| – | – | 0.15% | 67 |
|
|
2021
Q4 | $364K | Hold |
6,500
| – | – | 0.12% | 68 |
|
|
2021
Q3 | $312K | Hold |
6,500
| – | – | 0.12% | 68 |
|
|
2021
Q2 | $272K | Hold |
6,500
| – | – | 0.1% | 73 |
|
|
2021
Q1 | $219K | Hold |
6,500
| – | – | 0.08% | 77 |
|
|
2020
Q4 | $227K | Hold |
6,500
| – | – | 0.1% | 68 |
|
|
2020
Q3 | $226K | Hold |
6,500
| – | – | 0.11% | 67 |
|
|
2020
Q2 | $362K | Hold |
6,500
| – | – | 0.21% | 57 |
|
|
2020
Q1 | $196K | Hold |
6,500
| – | – | 0.12% | 69 |
|
|
2019
Q4 | $188K | Hold |
6,500
| – | – | 0.09% | 72 |
|
|
2019
Q3 | $168K | Hold |
6,500
| – | – | 0.09% | 72 |
|
|
2019
Q2 | $166K | Hold |
6,500
| – | – | 0.08% | 77 |
|
|
2019
Q1 | $170K | Hold |
6,500
| – | – | 0.09% | 72 |
|
|
2018
Q4 | $150K | Hold |
6,500
| – | – | 0.09% | 76 |
|
|
2018
Q3 | $153K | Hold |
6,500
| – | – | 0.07% | 92 |
|
|
2018
Q2 | $150K | Hold |
6,500
| – | – | 0.07% | 87 |
|
|
2018
Q1 | $160K | Hold |
6,500
| – | – | 0.09% | 88 |
|
|
2017
Q4 | $174K | Hold |
6,500
| – | – | 0.08% | 91 |
|
|
2017
Q3 | $156K | Hold |
6,500
| – | – | 0.07% | 84 |
|
|
2017
Q2 | $139K | Sell |
6,500
-200
| -3% | -$4.04K | 0.06% | 93 |
|
|
2017
Q1 | $115K | Hold |
6,700
| – | – | 0.06% | 100 |
|
|
2016
Q4 | $120K | Sell |
6,700
-200
| -3% | -$3.63K | 0.06% | 96 |
|
|
2016
Q3 | $143K | Hold |
6,900
| – | – | 0.06% | 122 |
|
|
2016
Q2 | $186K | Hold |
6,900
| – | – | 0.09% | 97 |
|
|
2016
Q1 | $187K | Sell |
6,900
-200
| -3% | -$5.36K | 0.09% | 96 |
|
|
2015
Q4 | $206K | Hold |
7,100
| – | – | 0.09% | 95 |
|
|
2015
Q3 | $193K | Hold |
7,100
| – | – | 0.09% | 104 |
|
|
2015
Q2 | $194K | Hold |
7,100
| – | – | 0.08% | 106 |
|
|
2015
Q1 | $190K | Hold |
7,100
| – | – | 0.08% | 114 |
|
|
2014
Q4 | $150K | Sell |
7,100
-200
| -3% | -$4.47K | 0.06% | 134 |
|
|
2014
Q3 | $174K | Hold |
7,300
| – | – | 0.08% | 115 |
|
|
2014
Q2 | $169K | Hold |
7,300
| – | – | 0.07% | 110 |
|
|
2014
Q1 | $167K | Sell |
7,300
-200
| -3% | -$4.26K | 0.06% | 109 |
|
|
2013
Q4 | $139K | Hold |
7,500
| – | – | 0.05% | 120 |
|
|
2013
Q3 | $127K | Hold |
7,500
| – | – | 0.05% | 140 |
|
|
2013
Q2 | $119K | Buy |
+7,500
| New | +$125K | 0.05% | 137 |
|
Other funds holding NVO
F
Cowen Prime Advisors's NVO Position: Q2 2023 in Review
Cowen Prime Advisors held its Novo Nordisk (NVO) position steady in Q2 2023 at 6,000 shares worth $485K. The position accounts for 0.17% of the portfolio, ranked #59.
Cowen Prime Advisors first reported a position in NVO in Q2 2013 and has held it in 41 quarters since. The position peaked at $501K in Q1 2023. 1,196 funds tracked by Wall St. Rank hold NVO as of Q2 2023.
- Cowen Prime Advisors held 6,000 shares of Novo Nordisk worth $485K as of Q2 2023.
- Cowen Prime Advisors left its Novo Nordisk share count unchanged in Q2 2023.
- Novo Nordisk made up 0.17% of Cowen Prime Advisors's portfolio in Q2 2023, its #59 holding.
- Cowen Prime Advisors first reported a position in Novo Nordisk in Q2 2013 and has held it in 41 quarters since.
- Cowen Prime Advisors's Novo Nordisk position peaked at $501K in Q1 2023.
- 1,196 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2023.
Based on Cowen Prime Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.